Musso G, Garofano G, Dabbas M, Meagher MF, Yuen KL, Birouty N, Baker B, Saitta C, Guer M, Montorsi F, Briganti A, Capitanio U, Larcher A, Salonia A, Derweesh IH. The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based Study. Clin Genitourin Cancer. 2025 Oct; 23(5):102412.

Massari F, Mollica V, Kopp RM, Grande E, Fiala O, Kanesvaran R, Li H, Schieber TJ, Juan Fita MJ, Poprach A, Lolli C, Bourlon MT, de Liaño AG, Grillone F, Sunela K, Rizzo A, Ghosn M, Cerbone L, Taha T, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, Lenci E, Martin IO, Abu-Sini H, Rescigno P, Bhuva D, Fay AP, Conteduca V, Yildirim A, Rosellini M, Akova U, Tassinari E, Bölek H, Soares A, Marques Monteiro FS, Buti S, Bilen MA, Santoni M. Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study. Eur Urol Focus. 2025 Sep; 11(5):736-746.

Groisser A, Frantz A, Geller JI, Ortiz MV, Walterhouse D, Ranalli M, Woods-Swafford W, Schoettler P, Garrington T, Mullen EA, Ash S, Bardhan P, Balis F, Dome JS. Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor. Pediatr Blood Cancer. 2025 Oct; 72(10):e31915.

Musso G, Birouty N, Salonia A, Garofano G, Dabbas M, Meagher MF, Yuen KL, Baker B, Saitta C, Patil D, Tanaka H, Kobayashi M, Fukuda S, Montorsi F, Briganti A, Capitanio U, Larcher A, Rosiello G, Fujii Y, Master VA, Derweesh IH. Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling. Urology. 2025 Nov; 205:99-107.

Benedetti DJ, Cost NG, Ehrlich PF, Evageliou N, Fialkowski E, Parsons LN, Vallance KL, Renfro LA, Hong AL, Aldrink JH, Pater L, Paulino AC, Sandberg JK, Smith EA, Treece AL, Dome JS, Geller JI, Mullen EA. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials. Nat Rev Urol. 2025 Nov; 22(11):775-788.

Menchaca AD, Srivatsa S, Kieran K, Fialkowski E, Soto A, Tracy ET, Romao RL, Kotagal M, Malek MM, Murphy AJ, Glick RD, Armstrong A, Cost NG, Aldrink JH. What Every Pediatric Surgeon Should Know About Common Systemic Therapies for the Treatment of Renal Tumors in Children and Adolescents. J Pediatr Surg. 2025 Sep; 60(9):162425.

Saitta C, Garofano G, Musso G, Tanaka H, Patil D, Nguyen V, Yuen KL, Baker B, Dabbas M, Meagher MF, Puri D, Birouty N, Baker O, Kobayashi M, Fukuda S, Paciotti M, Lughezzani G, Larcher A, Capitanio U, Melloni R, Catanzaro M, Nazzani S, Nicolai N, Fujii Y, Master V, Buffi N, Derweesh IH. UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion. World J Urol. 2025 Jun 04; 43(1):355.

van Peer SE, Treger TD, Wegert J, Hol JA, Le Gall J, Jakkula EE, Kamihara J, Mullen EA, Graf N, Behjati S, Al-Saadi R, Duncan C, Schienda J, de Putter R, Brzezinski J, Verschuur A, Michaeli O, Ortiz MV, Herkert JC, Armstrong R, Waanders E, Kuiper RP, van den Heuvel-Eibrink MM, Gessler M, Jongmans MCJ. Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants. Genet Med. 2025 Sep; 27(9):101478.

Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U, Puri D, Dabbas M, Birouty N, Yuen KL, Larcher A, Baker B, Autorino R, Pandolfo SD, Montorsi F, Lughezzani G, Casale P, Buffi NM, Derweesh IH. Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablation. Urol Oncol. 2025 Sep; 43(9):524.e9-524.e16.

Campwala I, Schienda J, Murphy AJ, Hashimi B, Perry T, Cost N, Kamihara J, Mullen EA, Santiago T, Malek MM. Wilms Tumor in Children With AMER1/WTX Germline Pathogenic Variants: A Multicenter Case Series. Pediatr Blood Cancer. 2025 Aug; 72(8):e31798.